Multiple Myeloma: Pharmacists as Therapy Experts | PTCE Pharmacy Connect
Description
Educational Objectives
- Objective 1: Describe a strategy to mitigate potential adverse effects of MM therapies by altering the route of administration, dosing schedule, and use of supportive care medications
Kathryn Maples, PharmD, BCOP
Clinical Pharmacy Specialist, Multiple Myeloma
Winship Cancer Institute, Emory Healthcare
Atlanta, Georgia
Kathryn Maples, PharmD, BCOP, has the following relevant financial relationships with commercial interests to disclose:
Consultant: GlaxoSmithKline, Janssen, Karyopharm, Sanofi
Pharmacy Times Continuing Education™ is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. This activity is approved for 0.5 contact hours (0.05 CEU) under the ACPE universal activity numbers 0290-0000-22-315-H01-P and 0290-0000-22-315-H01-T. The activity is available for CE credit through July 11, 2023.
This activity is supported by an educational grant from Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC.
United States
